Bridgefront Capital LLC Has $396,000 Stock Holdings in Intuitive Surgical, Inc. $ISRG

Bridgefront Capital LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 81.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 885 shares of the medical equipment provider’s stock after selling 3,902 shares during the period. Bridgefront Capital LLC’s holdings in Intuitive Surgical were worth $396,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of ISRG. Banco Bilbao Vizcaya Argentaria S.A. boosted its position in shares of Intuitive Surgical by 12.2% in the third quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 47,974 shares of the medical equipment provider’s stock valued at $21,442,000 after acquiring an additional 5,217 shares during the period. California Public Employees Retirement System increased its position in Intuitive Surgical by 3.5% during the third quarter. California Public Employees Retirement System now owns 623,347 shares of the medical equipment provider’s stock worth $278,779,000 after acquiring an additional 21,207 shares during the period. Chilton Investment Co. Inc. increased its position in Intuitive Surgical by 39.5% during the third quarter. Chilton Investment Co. Inc. now owns 1,034 shares of the medical equipment provider’s stock worth $462,000 after acquiring an additional 293 shares during the period. Bank of Nova Scotia raised its stake in Intuitive Surgical by 73.4% in the 3rd quarter. Bank of Nova Scotia now owns 602,496 shares of the medical equipment provider’s stock worth $269,453,000 after purchasing an additional 255,005 shares in the last quarter. Finally, BNP Paribas raised its stake in Intuitive Surgical by 2.3% in the 3rd quarter. BNP Paribas now owns 30,724 shares of the medical equipment provider’s stock worth $13,740,000 after purchasing an additional 703 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Patricia L. Wadors sold 220 shares of Intuitive Surgical stock in a transaction on Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the transaction, the vice president directly owned 660 shares of the company’s stock, valued at $326,673.60. This trade represents a 16.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 32,943 shares of company stock valued at $17,279,568. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Trading Up 2.4%

Shares of NASDAQ:ISRG opened at $483.46 on Tuesday. The firm has a 50 day moving average of $511.60 and a 200-day moving average of $513.03. The stock has a market capitalization of $171.69 billion, a PE ratio of 61.28, a PEG ratio of 3.64 and a beta of 1.66. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm’s quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.21 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. BTIG Research restated a “buy” rating and set a $616.00 target price on shares of Intuitive Surgical in a research report on Friday, January 23rd. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target for the company in a research report on Wednesday, March 11th. UBS Group set a $570.00 price target on Intuitive Surgical and gave the company a “neutral” rating in a research note on Tuesday, February 24th. Barclays set a $712.00 price target on Intuitive Surgical and gave the stock an “overweight” rating in a research report on Monday, January 26th. Finally, Robert W. Baird lowered their price objective on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research note on Friday, January 23rd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $615.86.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.